Skip to main content

ProShare Advisors LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1357955 BETHESDA, MD

Position in REGN

as of Mar 31, 2026 · filed Apr 27, 2026
Position Value
$117,748,018
-$24,496,816 QoQ
Shares Held
152,397
-17.3% QoQ
Ownership
0.145%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

ProShare Advisors LLC holds $466,686,133 across 164 Biotechnology names. REGN ranks #2 (25.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 REGN
Regeneron Pharmaceuticals, Inc.
This page
152,397 $117,748,018

All Filings in REGN

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $117,748,018 152,397
2025-12-31 $142,244,834 184,286
2025-09-30 $75,993,039 135,154
2025-06-30 $88,905,075 169,343
2025-03-31 $103,564,685 163,292
2024-12-31 $104,096,344 146,135
2024-09-30 $126,271,795 120,117
2024-06-30 $118,988,157 113,211
2024-03-31 $120,506,635 125,203
2023-12-31 $90,989,965 103,599
2023-09-30 $100,089,218 121,621
2023-06-30 $78,060,029 108,637
2023-03-31 $94,054,921 114,468
2022-12-31 $75,525,573 104,680
2022-09-30 $82,391,607 119,604
2022-06-30 $84,494,939 142,938
2022-03-31 $144,667,226 207,135
2021-12-31 $136,450,631 216,067
2021-09-30 $92,104,159 152,193
2021-06-30 $75,817,895 135,743
2021-03-31 $66,260,418 140,044
2020-12-31 $58,462,590 121,013
2020-09-30 $58,508,205 104,520
2020-06-30 $53,560,309 85,882
2020-03-31 $36,095,861 73,923